Portfolio

The Yushvaev family office invests into revolutionary companies focused on transformative and equitable outcomes for consumers. Gavril Yushvaev and his family office have spearheaded investments into a number of companies that provide life-changing products, from bio-technology to transportation.

Humacyte

A disruptive biotechnology company delivering universally implantable bioengineered human tissue at commercial scale. The company went public in 2021, valued at $1.1bn.

Roivant Sciences

A healthcare technology company focusing on developing transformative medicines that fight diseases from cancer to blood disorders.

Lyft

The US-based transport company, providing mobility via ride-sharing, scooters, cars and more. The company had its IPO in 2019, valued at $23.4bn.

Domo

A cloud-based data-visualization platform that provides businesses with the context needed for faster and better business decisions. The company had its IPO in 2018, valued at $510m.

Delivery Hero

A multinational online food delivery service, operating in over 70 countries and partnering with over half a million restaurants. The company had its IPO in 2017, valued at $5bn.

Bird

A micromobility company focused on electric scooters, present around the world and in over 400 cities. The company went public in 2021, valued at $2.3bn